Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCEC
1826
Capital Clean Energy Carriers
CCEC
$1.36B
| $3.99M | 0.01% |
159,662
+120,471
| +307% | +$2.86M |
|
1827
O-I Glass
OI
$1.05B
| $3.99M | 0.01% |
195,753
-596,047
| -75% | -$11.7M |
|
|
ITCL
1828
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
| $3.99M | 0.01% |
293,666
-12,800
| -4% | -$161K |
|
1829
Universal Technical Institute
UTI
$1.42B
| $3.98M | 0.01% |
1,152,600
+61,600
| +6% | +$208K |
|
|
SNT
1830
Senstar Technologies
SNT
$42.9M
| $3.96M | 0.01% |
526,949
-89,611
| -15% | -$595K |
|
1831
Trupanion
TRUP
$1.36B
| $3.96M | 0.01% |
278,700
+64,300
| +30% | +$981K |
|
1832
Seres Therapeutics
MCRB
$45M
| $3.95M | 0.01% |
17,540
-2,475
| -12% | -$502K |
|
1833
Standard Motor Products
SMP
$870M
| $3.95M | 0.01% |
80,300
+32,200
| +67% | +$1.6M |
|
|
NXTM
1834
DELISTED
NxStage Medical Inc.
NXTM
| $3.94M | 0.01% |
146,983
+62,200
| +73% | +$1.72M |
|
|
RENX
1835
DELISTED
RELX N.V.
RENX
| $3.94M | 0.01% |
212,517
+31,660
| +18% | +$551K |
|
1836
Azenta
AZTA
$1.49B
| $3.94M | 0.01% |
175,657
+38,300
| +28% | +$760K |
|
1837
PennyMac Financial
PFSI
$4.13B
| $3.93M | 0.01% |
230,407
-247,293
| -52% | -$4.28M |
|
1838
Magnachip Semiconductor
MX
$137M
| $3.93M | 0.01% |
411,131
+183,000
| +80% | +$1.44M |
|
1839
Park-Ohio Holdings
PKOH
$718M
| $3.92M | 0.01% |
109,000
+4,300
| +4% | +$177K |
|
1840
Triumph Financial Inc
TFIN
$1.87B
| $3.92M | 0.01% |
151,812
+46,412
| +44% | +$1.23M |
|
1841
Aviat Networks
AVNW
$282M
| $3.91M | 0.01% |
518,966
+58,868
| +13% | +$418K |
|
|
MODN
1842
DELISTED
MODEL N, INC.
MODN
| $3.9M | 0.01% |
373,200
-62,700
| -14% | -$611K |
|
|
DL
1843
DELISTED
China Distance Education Holdings Limited
DL
| $3.89M | 0.01% |
381,503
-6,121
| -2% | -$63.2K |
|
1844
Altimmune
ALT
$560M
| $3.89M | 0.01% |
15,970
+4,813
| +43% | +$2.57M |
|
1845
Network-1 Technologies
NTIP
$35.2M
| $3.89M | 0.01% |
801,500
+583,800
| +268% | +$2.31M |
|
|
HSNI
1846
DELISTED
HSN, Inc.
HSNI
| $3.88M | 0.01% |
104,578
-70,622
| -40% | -$2.53M |
|
|
TNAV
1847
DELISTED
Telenav Inc.
TNAV
| $3.88M | 0.01% |
448,300
-54,400
| -11% | -$457K |
|
1848
Alpha Pro Tech
APT
$55.7M
| $3.88M | 0.01% |
1,409,091
-96,319
| -6% | -$292K |
|
1849
Camtek
CAMT
$8.06B
| $3.87M | 0.01% |
1,016,600
+96,670
| +11% | +$349K |
|
1850
Primoris Services
PRIM
$4.35B
| $3.87M | 0.01% |
166,800
+28,900
| +21% | +$694K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.